Introduction. Medication adherence is a public health problem and this has not been previously studied in myasthenia gravis patients Aim. To determine if patients with myasthenia gravis are adherent to treatment and ...

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: To provide an estimated prevalence and describe the clinical features of myasthenia gravis (MG) in Chile. Method: We carried out (i) a prevalence ...

Abstract: Myasthenia gravis is a rare and invalidating disease affecting the neuromuscular junction of voluntary muscles. The classical form of this autoimmune disease is characterized by the presence of antibodies against ...

Myasthenia gravis (MG) is an autoimmune disease characterized by fluctuating muscle weakness, caused by impaired neuromuscular transmission. Patients with MG can present other autoimmune diseases in association, commonly ...

Myasthenia gravis (MG) is a rare autoimmune disease of the neuromuscu-lar junction. It is characterized by variable weakness and excessive fatigability of skeletal muscles. In the last few years, numerous reports have been ...

Acute muscle weakness (AMW) is a pediatric emergency. During diagnostic approach, it is crucial to obtain a detailed anamnesis, including: onset of weakness, history of associated febrile states, ingestion of toxic ...